The largest database of trusted experimental protocols

16 protocols using srt1720

1

Erythroid Progenitor Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
De-identified peripheral blood samples from adults and cord blood were purchased from Research Blood Components, LLC (Boston, MA 02135) and New York Blood Center, Inc. (New York, NY 10065). Erythroid progenitors were cultured in a two-phase system, as previously described.29 –31 (link) Briefly, mononuclear cells from adult peripheral blood (PBMC) or cold blood were isolated on Ficoll-Paque (GE Healthcare, Piscataway, NJ), and cultured in a two-phase culture system.29 The first phase media utilized HyClone™ IMDM (Thermo Scientific, Waltham, MA) containing 30% charcoal treated fetal bovine serum (Life Technology, New York, NY) and rHuIL-3 (25 ng/mL), rHuSCF (50 ng/mL), and rHuEPO at (0.1 u/mL) (GenScript, Piscataway, NJ) for the first 7 days, followed by replacement second phase differentiation media, with 30% charcoal treated fetal bovine serum, rHuEPO at 3 U/mL, and rHuIL-3 (0.1 ng/mL). Test compounds SRT2104 (APExBIO, Houston, TX) and SRT1720 (EMD Millipore, Billerica, MA) were added 4 days after initiation of the Phase 2 erythroid differentiation cultures. Erythroid progenitors were confirmed by Giemsa stain.29 Cells were enumerated by hemocytometry and harvested on day 12 of phase 2 for mRNA and ChIP analysis, and on day 14 for F-cell analysis by flow cytometry and for γ-globin analysis by immunoblotting.
+ Open protocol
+ Expand
2

APAP-Induced Liver Injury Model in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male C57BL/6J mice (8–12 weeks old) were purchased from Jackson Laboratories (Bar Harbor, ME) and kept in an environmentally controlled room with a 12 h light/dark cycle and ad libitum access to food (LabDiet® PicoLab® Rodent Diet 20, #5053 Purina, Missouri, USA) and water. Mice were i.p. treated with 200 or 300 mg/kg APAP (Sigma-Aldrich) dissolved in warm saline after overnight fasting, and euthanized at the indicated time points between 0 and 96h after APAP injection for collection of blood and liver samples. SRT1720 (EMD Millipore) was dissolved in 10% DMSO plus 2% Tween 20 and was i.p. administered at either 1.5h or 12h and 36h post-APAP. All vehicle control mice received the same volume of DMSO (1 mL/kg) and Tween 20 (0.2 mL/kg). Blood was drawn from the caudal vena cava using a heparinized syringe. The liver was divided into several pieces some of which were used for mitochondrial isolation (Du et al., 2015 ), others for embedding in OCT medium for immunofluorescent staining or fixing in 10% phosphate-buffered formalin for histological analysis. The remaining pieces were snap-frozen in liquid nitrogen and stored at −80°C for later analyses. All experimental protocols were approved by the Institutional Animal Care and Use Committee of the University Kansas Medical Center and followed the criteria of the National Research Council for the care and use of laboratory animals.
+ Open protocol
+ Expand
3

Therapeutic Effects of SRT1720 and Polydatin in TBI

Check if the same lab product or an alternative is used in the 5 most similar protocols
The first experiment analyzed ROS production, mitochondrial injury-related indicators, ER stress and apoptosis-related proteins. The rats were randomized into the sham group, the TBI group, the TBI + SRT1720 group and the TBI+ polydatin group. SRT1720 (SIRT1 agonist, 20 mg/kg; Merck Millipore, Boston, MA, USA) was intraperitoneally injected immediately following TBI (Khader et al., 2017). Polydatin (30 mg/kg; Haiwang, Shenzhen, China) was intraperitoneally injected immediately following TBI (n = 18/group) (Wang et al., 2013). Each rat injured-side cortex was isolated at 6 hours post-TBI. The second experiment analyzed neurological score, including a sham-treated control group, as well as groups sacrificed at 6, 12, 24, 72, and 168 hours post-TBI (n = 6/group). The third experiment analyzed survival. The rats were randomized into the sham group, the TBI group, the TBI + SRT1720 group and the TBI + polydatin group (n = 10/group).
+ Open protocol
+ Expand
4

SIRT1 Modulation in Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
Modulation of SIRT1 activity was performed using an inhibitor, EX-527 (5μmol/L, Sigma) for 6 hours prior to the start of the experiment, or with an activator SRT1720 (0.16μmol/L, Sigma) for 1 hour prior to the start of the experiment.
+ Open protocol
+ Expand
5

SIRT1 Regulation of Apoptosis Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
High-glucose Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS) and trypsin were purchased from Dow Corning (Midland, MI, USA). Methyl thiazolyl tetrazolium (MTT) kit and Annexin V cell apoptosis kit were purchased from Nanjing KeyGen Biotech Co., Ltd. (Nanjing, China). M-MuLV Reverse Transcriptase kit and SYBR-Green I real-time fluorescence quantitative polymerase chain reaction (PCR) kit were purchased from Thermo Fisher Scientific, Inc. (Waltham, MA, USA). SIRT1 agonist SRT1720 and inhibitor EX527 were from Sigma-Aldrich (Sigma-Aldrich: Merck KGaA, St. Louis, MO, USA) [dissolved at 1 mmol/l with dimethylsulfoxide (DMSO), and stored at −20°C in the dark]. Primary mouse anti-human SIRT1, p53, B-cell lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax) and β-actin monoclonal antibodies, and horseradish peroxidase-labeled secondary goat anti-mouse polyclonal antibody (cat. nos. sc-135792, sc-47698, sc-509,sc-20067, sc-58673 and sc-2005, were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). SIRT1, p53 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene primer sequences were synthesized by Nanjing KeyGen Biotech Co., Ltd.
The study was approved by the Ethics Committee of the Second Hospital of Shandong University (Jinan, China). Informed consents were signed by the patients and/or guardians.
+ Open protocol
+ Expand
6

D-Galactose-Induced Cellular Senescence Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human normal tubular epithelial cell (HK-2) was purchased from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). DMEM/F12 medium and 0.25% trypsin solution were obtained from Biological Industries (Israe). D-galactose and SRT1720 were bought from Sigma (Germany). Astragaloside IV was obtained from Dalian Meilun Biotechnology Co., Ltd (China). The CCK-8 detection kit and horseradish peroxidase (HRP)-conjugated secondary goat antirabbit antibody were obtained from Wuhan Boster Biological Technology., Ltd (China). The β-Galactosidase Assay Kit was purchased from Beyotime Biotechnology (China). The Enzyme-Linked Immunosorbent Assay (ELISA) kit for the detection of transforming growth factor-β (TGF-β) and interleukin (IL)-6 were bought from Jiangsu Maisha Industrial Co., Ltd (China). Primary antibodies of silent information regulation 2 homolog 1 (SIRT1), P53, and P21 were purchased from Cell Signaling Technology (USA).
+ Open protocol
+ Expand
7

SIRT1 Activation and Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Palmitic acid (PA) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Primary antibodies against SIRT1, PGC-1α, and VEGFA were purchased from Abcam (Cambridge, UK). We purchased SRT1720, a SIRT1 activator, and EX-527, a SIRT1 inhibitor, from Sigma-Aldrich, dissolved in dimethyl sulfoxide (DMSO) at a concentration of 5 mg/mL, and stored at −80 ℃.
+ Open protocol
+ Expand
8

TET2 Modulation in MCF-7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
MCF-7 cells stably transfected with an EV or with plasmids encoding either the wild-type mouse TET2 catalytic domain (CD; aa916-1921, pcDNA3-Flag-TET2 CD, addgene #72219, (18 (link))) or the catalytically dead mutant H1304Y, D1306A (pcDNA3-Flag-TET2 mCD, #72220; Addgene (18 (link))) were grown in high-glucose and pyruvate-containing DMEM (41966; Gibco) supplemented with 10% fetal calf serum (S116365181H; Eurobio), nonessential amino acids (11140035; Gibco), penicillin–streptomycin (15240; Gibco), and Geneticin (11811064; Gibco) at 37°C and 5% CO2. The SIRT1 activator compound SRT1720 was purchased from Sigma-Aldrich (567860), and chloroquine was from the CYTO-ID Autophagy Detection Kit 2.0 (ENZO ENZ-KIT175). Decitabine (5-aza-deoxycytidine) was from Sigma-Aldrich (A3656). For RT-qPCR analysis, cells were treated with 100 nM decitabine given every 36 h, for 96 h.
+ Open protocol
+ Expand
9

Resveratrol and miR-182 Antagomir for Neuropathic Pain

Check if the same lab product or an alternative is used in the 5 most similar protocols
Resveratrol (#R5010) was purchased from Sigma-Aldrich Co. LLC, St. Louis, Missouri and dissolved in 100% DMSO. Sirt1 inhibitor EX527 (#E7034) and Sirt1 activator SRT1720 (#567,860) were also purchased from Sigma-Aldrich, and dissolved in DMSO. miR-182 antagomir and antagomir negative control were synthesized by BGI-Shenzhen (Shenzhen, China) using the sequences listed previously[14]. Most drugs were administered via the pre-placed intrathecal catheter once per day 7 days after CCI for 4 successive days except EX527, which was injected s.c. with the same time pattern. Rats were randomly divided into the following groups. For the CCI group, rats received CCI surgery to establish neuropathic pain model. For the sham group, rats received the same surgery procedures except nerve ligation. For sham+EX527 group, sham animals were injected 10 mg/kg EX527. For CCI+SRT1720, 5 μl SRT1720 (5 μg) was injected into CCI rats. For the CCI+ Resveratrol, 10 μl Resveratrol (300 μg) was injected. For the CCI+Res.+miR-182antagomir group, 10 μl Resveratrol (300 μg) as well as 2 μl miR-182 antagomir (20 μM) were injected. For CCI+Res.+miR-182anta. -N.C group, 10 μl Resveratrol as well as 2 μl miR-182 antagomir negative control (20 μM) were injected.
+ Open protocol
+ Expand
10

Evaluating SCIC2 and SCIC2.1 Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
SCIC2 and SCIC2.1 were purchased from Enamine and used in all experiments at a final concentration of 50 μM and 25 μM, respectively. DOXO (Pfizer) was used at a final concentration of 0.5 μM. SRT1720 and Ex-527 (Sigma-Aldrich) were used at 5 μM. Dimethyl sulfoxide (DMSO; Sigma-Aldrich) was used to dissolve the drugs.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!